BioXcel Therapeutics (BTAI)
Develops neuroscience therapies through a data-driven drug re-innovation model.
$0.0739
0.00 (0.00%)
Delisted · Sep 8, 2026
Something off on this page? Send us feedback.
Next report
Nov 11, 26
in 49 days
EPS estimate
−$1.01
Revenue estimate
$191.4K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$3.57−$1.50−$2.45−$2.18−$0.58−$0.54−$0.49Pending
Estimate−$4.36−$2.72−$2.30−$1.54−$0.34−$0.59−$0.44−$1.01
Surprise+18.1%+44.9%−6.5%−41.6%−70.6%+8.5%−11.4%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$366.0K$168.0K$120.0K$98.0K$256.0K$206.0K$182.0KPending
Estimate$718.3K$350.0K$257.5K$169.0K$151.5K$381.5K$484.6K$191.4K
Surprise−49.0%−52.0%−53.4%−42.0%+69.0%−46.0%−62.4%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.26 | — | — |
| Sep 2027 | −$0.26 | — | — |
| Jun 2027 | −$0.29 | — | — |
| Mar 2027 | −$0.31 | — | — |
| Dec 2026 | −$0.72 | — | — |
| Nov 2026 | −$1.01 | — | — |
| Aug 2026 | −$0.44 | −$0.49 | −11.4% |
| May 2026 | −$0.59 | −$0.54 | +8.5% |
| Mar 2026 | −$0.34 | −$0.58 | −70.6% |
| Nov 2025 | −$1.54 | −$2.18 | −41.6% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Dec 2017 | |||
| Mar 2018 | |||
| Jun 2017 | |||
| Mar 2017 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.26 | — | — | $1.7M | — | — | — |
| Sep 2027 | −$0.26 | — | — | $1.5M | — | — | — |
| Jun 2027 | −$0.29 | — | — | $1.3M | — | — | — |
| Mar 2027 | −$0.31 | — | — | $800.0K | — | — | — |
| Dec 2026 | −$0.72 | — | — | $190.5K | — | — | — |
| Nov 11, 2026 | −$1.01 | — | — | $191.4K | — | — | — |
| Aug 13, 2026 | −$0.44 | −$0.49 | −11.4% | $484.6K | $182.0K | −62.4% | +6.6% |
| May 15, 2026 | −$0.59 | −$0.54 | +8.5% | $381.5K | $206.0K | −46.0% | −5.8% |
| Mar 26, 2026 | −$0.34 | −$0.58 | −70.6% | $151.5K | $256.0K | +69.0% | −4.2% |
| Nov 12, 2025 | −$1.54 | −$2.18 | −41.6% | $169.0K | $98.0K | −42.0% | −15.4% |
| Aug 12, 2025 | |||||||
| May 12, 2025 | |||||||
| Mar 27, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 6, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 12, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 8, 2023 | |||||||
| Mar 9, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 9, 2022 | |||||||
| Mar 10, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 10, 2021 | |||||||
| May 10, 2021 | |||||||
| Mar 11, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Aug 14, 2020 | |||||||
| May 12, 2020 | |||||||
| Mar 9, 2020 | |||||||
| Nov 14, 2019 | |||||||
| Aug 6, 2019 | |||||||
| May 7, 2019 | |||||||
| Mar 7, 2019 | |||||||
| Nov 9, 2018 | |||||||
| Aug 8, 2018 | |||||||
| May 14, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Mar 12, 2018 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 |